In the field of neuropsychological assessment of cognitive impairment, it is essential to have tools that allow for the structured, objective evaluation of clinical progression. The GDS scale (Global Deterioration Scale), developed by Barry Reisberg, is a benchmark in this regard. Although it was initially designed for Alzheimer’s disease, its clinical utility has been extended to other types of dementia and mild cognitive impairment. This article explains what the GDS scale is and how it is used.
What exactly is the GDS scale, or Global Deterioration Scale?
The Reisberg GDS scale is a clinical tool that classifies a person’s cognitive status across seven stages. It ranges from normal functioning (GDS 1) to very severe dementia (GDS 7). Its purpose is to provide a standardized framework for assessing cognitive decline, guiding clinical intervention, and monitoring disease progression. Each stage corresponds to a set of observable symptoms and is associated with a level of functional dependence. Unlike many cognitive assessment tools that rely on numerical scores, the GDS is descriptive rather than quantitative, although it correlates well with standardized cognitive tests.
GDS Scale Scoring
Below, we will examine the GDS scale scores corresponding to each clinical interpretation.
GDS 1
Corresponds to normal cognitive functioning. There are no subjective complaints about memory or objective findings on evaluation. The individual shows no detectable impairment.
GDS 2
There are benign memory lapses or subjective complaints. Age-related memory lapses (such as forgetting names or where objects were placed) occur, but without functional impairment. This level may complicate the differential diagnosis with incipient impairment.
GDS 3
Mild cognitive impairment is present. Objective deficits begin to be observed on tests of memory, attention, or planning. Work or social functioning is affected. This may correspond to a clinical diagnosis of MCI (mild cognitive impairment).
GDS 4
Moderate cognitive impairment is observed. The person being evaluated has clear difficulties with tasks such as managing finances or planning activities. Some autonomy is maintained, but with occasional supervision. This stage marks the clinical onset of dementia.
GDS 5
There is moderately severe impairment. At this level of the GDS-5, assistance is required for basic activities of daily living (ADLs) (dressing, preparing meals, personal hygiene), although basic information—such as one’s own name or the names of close family members—is still retained.
GDS 6
Severe impairment is present. Episodic memory, language, and orientation are affected. Continuous assistance is needed. Behavioral and sleep disturbances are common.
GDS 7
This represents very severe or end-stage impairment. Functional speech, motor control, and the ability to recognize close relatives are lost. The patient is completely dependent and may require palliative care.
What is the neuropsychological applicability of Reisberg’s GDS scale?
From a neuropsychological perspective, the Global Deterioration Scale (GDS) allows the results obtained from neuropsychological tests contextualizes results from neuropsychological tests within a developmental framework. Its usefulness lies in:
- Standardize clinical communication among professionals.
- Correlate levels of impairment with objective functional outcomes.
- Guide the selection of appropriate neuropsychological tests.
- Determine whether the individual can participate in cognitive rehabilitation or stimulation programs.
Furthermore, it facilitates explaining the diagnosis to family members and caregivers by using an understandable structure without sacrificing clinical rigor. In GDS-3 or GDS-4 stages, when executive functions begin to be compromised, it is especially useful to supplement this scale with computerized tools to assess attention, working memory, inhibitory control, and processing speed. The global deterioration scale test serves as a cornerstone of neuropsychological interpretation, especially when conducting longitudinal follow-up or assessing subtle functional changes, for example, in the context of neurological disorders.
References:
- Fundación Pasqual Maragall. (2020, 13 de marzo). Escalas FAST y GDS: formas de gradación del Alzheimer. Fundación Pasqual Maragall. https://fundacionpasqualmaragall.org/alzheimer-y-demencia/escalas-fast-y-gds-formas-de-gradacion-del-alzheimer
- Custodio, N., Becerra-Becerra, Y., Alva-Díaz, C., Montesinos, R., Lira, D., Herrera-Pérez, E., & Castro-Suárez, S. (2017). Validación y precisión de la escala de deterioro global (GDS) para establecer severidad de demencia en una población de Lima. Medicina (Lima), 31(1), 14-26. https://doi.org/10.21615/cesmedicina.31.1.2
- Kayhan Koçak, F. O., & Kumral, E. (2025). The relationship between dementia staging scales, cognitive-behavioral scales and functionality in patients with cognitive impairment. PLOS ONE, 20(5). https://doi.org/10.1371/journal.pone.0322572
- Rodríguez-Hidalgo, E., et al. (2023). The Global Deterioration Scale for Down Syndrome: Adaptation and validation for systematic tracking of Alzheimer’s disease. Journal of Intellectual Disability Research. https://doi.org/10.3390/ijerph20065096